agreed, bought more stock today and sold a few puts. USO is green, stocks still down and recently down much more than USO thanks to the shorts. BUY IMO.
Sell calls when a stock is overbought, not oversold. I sold the June 7.5 calls a few weeks ago, which look to be expiring worthless. Not planning to sell any calls at this price level. IMO of course.
I thinks charts are very useful for those skilled in reading them. BBEP is very oversold and I continue to average down based on their hedges and my belief that oil will not stay below the cost of drilling for years. Maybe a few more months, maybe another 6-12 months, but BBEP should be OK and the div is high, coverage ratio is high. Don't let the liars bring you down.
it's a chicken and egg thing. If the stock dist rate is not above the bond rates, investors will prefer the bonds or preferred since they have less default risk.
Just 2 short posters with thumbs down? I would think Chanos can afford more MB activity based on his articles, media, press, etc.
BBEP should not be trading with the price of oil in the short run since they are hedged out 18-24 mos. By then, supply will decline and price will rise IMO. Patience, accumulate the dips. BBEP is selling at 40% of book due to the fear of debt and low oil prices. Low prices will cure low prices over time and the hedged will own the unhedged. Less
1) who cares about MNKD, inhaled insulin has already been tried and failed 2) The $ amount 30MM shares x the current price is huge. If a squeeze gets any legs, this could get ugly for them. The big squeeze is often discusses, rarely happens.
From Guy's lips to God's ears. It seems the last time he said he was a buyer, the stock faded. The short position is very large and a squeeze would be nice!
around $28 looks like the next resistance. Technicals are getting a little stretched in the absence of some fundamental news.
no problem, 1:10 split gets it done. Or, maybe one day they will make progress with the pipeline. Jack promised it would be this year, so if he fails, he's GONE!
took profits at 3.75 and sold my USO calls near the high and starting to get tempted at $3 GTE. If my BBEP was not getting smoked every day...Thanks Jim Chanos!
they could try cutting the flippin burn rate, but Jack is too weak to make the overdue cost reductions. If they don't cut headcount, they will have to start partnering earlier to reduce clinical dev costs for the pipeline. Unfortunately, Jack's Bean counter is also too weak to stand up to Jack, so they keep choosing dilution. We should be good for at least another year before the next round.
I tried to cut and past the primary and secondary measures, but Yahoo is wiping it out. Everyone should go to clinical trials DOT gov and review this trial. It's one of the last trials on page 1 of Belviq. The trial is nothing less than make, or break. If this trial goes well, ARNA/Bel could rule the market because just about every measure is tested. If it goes poorly, who knows, but it would not be good.
that was just R9 buying back his 10% trading shares. Did they test for pre-diabetes or delaying the on-set. I guess I could also navigate the internet and go to the FDA site to check for myself.